Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Ice massage, massage guns or rest? Runners tried three ways to recover

11

Nov 2026

Ice massage, massage guns or rest? Runners tried three ways to recover

In a randomized trial of 80 recreational runners, repeated ice massage, percussive massage, and combined treatment improved reactive strength, reduced muscle soreness, and produced greater reductions in calf and Achilles tendon stiffness over 72 hours than passive rest. Combined treatment produced the largest improvement in reactive strength, although its advantage over individual treatments was based on exploratory comparisons, and none of the interventions showed a sustained benefit for the biochemical marker LDH.

Experimental cell therapy helps ordinary skin mimic tough palm tissue

11

Nov 2026

Experimental cell therapy helps ordinary skin mimic tough palm tissue

In a phase I clinical trial funded by the National Institutes of Health and the Maryland Stem Cell Research Fund, Johns Hopkins Medicine researchers say they have partially transformed ordinary human skin cells into volar skin - the durable skin found exclusively on the palms and soles that resists friction and pressure.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.